Posts with tag: recording
Quarterly revenue of $2.45 billion for Biogen ($BIIB) exceeded analysts' predictions by 2.9%. Although the non-GAAP EPS of $3.44 per share was modestly better than expectations, the yearly EPS projection of $15.73 missed estimates by 3.1%. Investigate Biogen's financial performance and determine if it presents a desirable investment opportunity by reading our thorough research report.
Published on: February 12, 2025, 01:00 PM UTC